Castleark Management’s NEVRO CORP. NVRO Stock Holding History

Castleark Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-55,555	Closed	-$9.62M	–	379
2020 Q4	$9.62M	Sell	55,555 -22,825	-29%	-$3.7M	0.36%	69
2020 Q3	$10.9M	Buy	78,380 +11,947	+18%	+$1.6M	0.43%	60
2020 Q2	$7.94M	Sell	66,433 -15,645	-19%	-$1.86M	0.35%	79
2020 Q1	$8.21M	Buy	+82,078	New	+$9.87M	0.49%	56
2017 Q2	–	Sell	-160,655	Closed	-$15.1M	–	436
2017 Q1	$15.1M	Buy	+160,655	New	+$14.6M	0.47%	54
2016 Q4	–	Sell	-47,460	Closed	-$4.95M	–	426
2016 Q3	$4.95M	Sell	47,460 -21,415	-31%	-$1.93M	0.15%	179
2016 Q2	$5.08M	Buy	68,875 +3,460	+5%	+$235K	0.16%	169
2016 Q1	$3.68M	Buy	+65,415	New	+$3.86M	0.11%	205
2015 Q3	–	Sell	-137,490	Closed	-$7.39M	–	410
2015 Q2	$7.39M	Buy	+137,490	New	+$7M	0.2%	142

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Castleark Management's NVRO Position: Q1 2021 in Review

Castleark Management sold out of NEVRO CORP. (NVRO) in Q1 2021, closing a stake of 55,555 shares — an estimated $9.62M sold.

Castleark Management first reported a position in NVRO in Q2 2015 and held it in 9 quarters. The position peaked at $15.1M in Q1 2017. 204 funds tracked by Wall St. Rank hold NVRO as of Q1 2021.

Castleark Management reported no remaining NEVRO CORP. position as of Q1 2021 after selling out during the quarter.
Castleark Management sold 55,555 NEVRO CORP. shares in Q1 2021, an estimated $9.62M.
Castleark Management first reported a position in NEVRO CORP. in Q2 2015 and held it in 9 quarters.
Castleark Management's NEVRO CORP. position peaked at $15.1M in Q1 2017.
204 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2021.

Based on Castleark Management's 13F filing for Q1 2021, filed 14 May 2021.